Chronic systemic inflammation in diabetes also impairs plaque healing and promotes a procoagulant state (e.g., via elevated fibrinogen and plasminogen activator inhibitor‐1 [PAI‐1]), compounding the risk of plaque thrombosis [30]. This evidence concerns the gene SERPINE1 and diabetes mellitus.